Regulation 208 Amendment of regulation 269 (offences relating to packaging and package leaflets: other persons)I1

United Kingdom

(1)

Regulation 269 M1 is amended as follows.

F1(1A)

In the heading to the regulation, after “packaging and package leaflets” insert “in Great Britain”.

F2(2)

In paragraph (1)—

(a)

for “marketing authorisation, Article 126a authorisation” substitute “UKMA(UK), UKMA(GB)”;

(b)

after “the purpose of sale or supply” insert “, in Great Britain”.

F3(2A)

In paragraph (2), after “for the purpose of sale or supply,” insert “in Great Britain”.

(3)

In paragraph (2)(a)—

(a)

for “Article 28 or 32 of the Paediatric Regulation” substitute “ regulation 50C(4), 50D(8) or 58A(2)(b) ”; and

(b)

omit “, Article 9 of Commission Regulation 2016/161”.

Annotations

F1: Reg. 208(1A) inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 163(a)
F2: Reg. 208(2) substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 163(b)
F3: Reg. 208(2A) inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 163(c)

I1: Reg. 208 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1